$19,22
+$0,23(+1,21 %)
*Data last updated: 2026-05-23 10:33 (UTC+8)
As of 2026-05-23 10:33, Baxter International Inc. (BAX) is priced at $19,22, with a total market cap of $9,90B, a P/E ratio of -10,24, and a dividend yield of 1,87 %. Today, the stock price fluctuated between $18,61 and $19,67. The current price is 3,27 % above the day's low and 2,28 % below the day's high, with a trading volume of 6,23M. Over the past 52 weeks, BAX has traded between $18,34 to $19,67, and the current price is -2,28 % away from the 52-week high.
BAX Key Stats
Yesterday's Close$19,03
Market Cap$9,90B
Volumen6,23M
P/E Ratio-10,24
Dividend Yield (TTM)1,87 %
Dividend Amount$0,01
Diluted EPS (TTM)2,14
Net Income (FY)-$957,00M
Revenue (FY)$11,24B
Earnings Date2026-07-30
EPS Estimate0,38
Revenue Estimate$2,79B
Shares Outstanding520,53M
Beta (1Y)0.621
Ex-Dividend Date2026-05-29
Dividend Payment Date2026-07-01
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOAndrew Hider
HeadquartersDeerfield,IL,US
Official Websitehttps://www.baxter.com
Employees (FY)37,50K
Average Revenue (1Y)$299,84K
Net Income per Employee-$25,52K
Erfahren Sie mehr über Baxter International Inc. (BAX)
Baxter International Inc. (BAX) FAQ
What's the stock price of Baxter International Inc. (BAX) today?
x
Baxter International Inc. (BAX) is currently trading at $19,22, with a 24h change of +1,21 %. The 52-week trading range is $18,34–$19,67.
What are the 52-week high and low prices for Baxter International Inc. (BAX)?
x
What is the price-to-earnings (P/E) ratio of Baxter International Inc. (BAX)? What does it indicate?
x
What is the market cap of Baxter International Inc. (BAX)?
x
What is the most recent quarterly earnings per share (EPS) for Baxter International Inc. (BAX)?
x
Should you buy or sell Baxter International Inc. (BAX) now?
x
What factors can affect the stock price of Baxter International Inc. (BAX)?
x
How to buy Baxter International Inc. (BAX) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
